1McColl KE.Helicobacter pylori and eesophageal cancer-not always protective.Gut,2007,56:457-469.
2Cremonini F,Di Caro S,elgado-Aros S,et al.Meta-analysis:the relationship between Helicobacter pylori infection and gastrooesophageal reflux disease.Aliment Pharmacol Ther,2003,18:279-289.
3Raghunath A,Pali A,Hungin S,et al.Prevalence of Helicobacter pylori in patients with gastrooesophageal reflux disease:systematic review.BMJ,2003,326:737-739.
4Weston AP,Badr AS,Topalovski M,et al.Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD,Barrett's esophagus,Barrett's dysplasia,and Barrett's adenocarcinoma.Am J Gastroenterol,2000,95:387-394.
5Loffeld RJ,Werdmuller BF,Kuster JG,et al.Colonization with cagA-positive Helicobacter priori strains inversely associated with reflux esophagitis and Barrett's esophagus.Digestion,2000,62:95-99.
6Vaezi MF,Falk GW,Peek RM,et al.CagA-positive strains of Helicobacter pylori may protect against Batrett's esophagus.Am J Gastroenterol,2000,95:2206-2211.
7Pereira-Lima JC,Marques DL,Pereira-Lima LF,et al.The role of cagA Helicobacter pylori strains in gastro-oesophageal reflux disease.Eur J Gastroenterol Hepatol,2004,16:643-647.
8Kim BC,Yoon YH,Jyung HS,et al.Clinical characteristics of gastroesophageal reflux diseases and association with Helicobacter pylori infection.Korean J Gastrcenterol,2006,47:363-369.
9Rokkas T,Ladas SD,Trianhafyllou K,et al.The association between CagA shams and the development of esophagitis after the eradication of Helicobacter pylori.Am J Med,2001,110:703-707.
10Vakil N,Talley NJ,Stoite M,et al.Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-uleer dyspepsia.Aliment Pharmacol Ther,2006,24:55-63.
5Abbas Z, Fareed R, Baig M N, et al. Prevalence of histological reflux oesophagitis in H. pylori positive patients: effect of density of H. pylori and activity of inflammation[J]. J Pak Med Assoc, 2001, 51(1): 36-41.
6Rajendra S, Ackroyd R, Robertson I K, et al. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East[J]. Helicobacter, 2007, 12(2) : 177 -183.
7Rugge M, Russo V, Busatto G, et al. The phenotype of gastric mucosa coexisting with Barrett' s oesophagus[ J]. J Clin Pathol, 2001,54 (6) : 456 -460.
8Giral A, Celikel C A, Ozdogan O, et al. Impact of Helicobacterpylori eradication on the anti-secretory efficacy of lansoprazole in gastroe- sophageal reflux disease patients[J]. J Gastroenterol Hepatol, 2005, 20(12) : 1886 - 1891.
9Malfertheiner P, Peitz U. The interplay between Helicobacter pylori, gastro -oesophageal reflux disease, and intestinal metaplasia[ J ]. Gut, 2005, 54( Suppl 1) : i13 -i20.
10Kudo M, Gutierrez O, El-Zimaity H M, et al. CagA in Barrett' s oesophagus in Colombia, a country with a high prevalence of gastric cancer[ J ]. J Clin Pathol, 2005, 58 (3) : 259 - 262.
6Ling FC, Baldus SE, Khochfar J, et al. Association of COX-2ex- pression with corresponding active and chronic inflammatory reac- tions in Barrett's meta plasia and progression to cancer[ J]. Histo- pathology ,2007,50( 8 ) :203-209.
7Song HJ,Shim KN,Yoon S J. The prevalence and clinical characteristics of reflux esophagitis in Roreans and its possible relation to metabolic syndrome[J].J Korean Med Sc,2009.197-202.
8Lin SR,Xu GM,Hu PJ. China consensus on gastroesophageal reflux disease[J].Chinese Journal of Gastroenterology,2007.233-237.
9McColl KE. Helicobacter pylori and oesophageal cancer-not always protective[J].Gut,2007.457-459.
10Kim BC,Yoon YH,Jyung HS. Clinical characteristics of gastroesophageal reflux diseases and association with Helicobacter pylori infection[J].Korean Journal of Gastroenterology=taehan Sohwagi Hakhoe Chi,2006.363-369.
